The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies
Open accessAbstract
BACKGROUND: The role of atrial fibrillation in cognitive impairment and dementia, independent of stroke, is uncertain. We sought to determine the association of atrial fibrillation with cognitive and physical impairment in a large group of patients at high cardiovascular risk. METHODS: We conducted a post-hoc analysis of two randomized controlled trials involving 31,546 patients, the aims of which were to evaluate the efficacy of treatment with ramipril plus telmisartan (ONTARGET) or telmisartan alone (TRANSCEND) in reducing cardiovascular disease. We evaluated the cognitive function of participants at baseline and after two and five years using the Mini-Mental State Examination (MMSE). In addition, we recorded incident dementia, loss of independence in activities of daily living and admission to long-term care facilities. We used a Cox regression model adjusting for main confounders to determine the association between atrial fibrillation and our primary outcomes: a decrease of three or more points in MMSE score, incident dementia, loss of independence in performing activities of daily living and admission to long-term care. RESULTS: We enrolled 31,506 participants for whom complete information on atrial fibrillation was available, 70.4% of whom were men. The mean age of participants was 66.5 years, and the mean baseline MMSE score was 27.7 (standard deviation 2.9) points. At baseline, 1016 participants (3.3%) had atrial fibrillation, with the condition developing in an additional 2052 participants (6.5%) during a median follow-up of 56 months. Atrial fibrillation was associated with an increased risk of cognitive decline (hazard ratio [HR] 1.14, 95% confidence interval [CI] 1.03-1.26), new dementia (HR 1.30, 95% CI 1.14-1.49), loss of independence in performing activities of daily living (HR 1.35, 95% CI 1.19-1.54) and admission to long-term care facilities (HR 1.53, 95% CI 1.31-1.79). Results were consistent among participants with and without stroke or receiving antihypertensive drugs. INTERPRETATION: Cognitive and functional decline are important consequences of atrial fibrillation, even in the absence of overt stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Debette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328
Silent brain infarcts: a systematic review
Vermeer, S. E., Longstreth, W. T., & Koudstaal, P. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70170-9 · Cited by 1,221
Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study
Ott, A., Breteler, M. M. B., de Bruyne, M. C., van Harskamp, F., Grobbee, D. E., & Hofman, A. (1997) · Stroke · doi:10.1161/01.str.28.2.316 · Cited by 732
Atrial fibrillation and cognitive decline: A longitudinal cohort study
Thacker, E. L., McKnight, B., Psaty, B. M., Longstreth, W. T., Sitlani, C. M., Dublin, S., Arnold, A. M., Fitzpatrick, A. L., Gottesman, R. F., & Heckbert, S. R. (2013) · Neurology · doi:10.1212/wnl.0b013e31829a33d1 · Cited by 222
Miyasaka, Y., Barnes, M. E., Petersen, R. C., Cha, S. S., Bailey, K. R., Gersh, B. J., Casaclang-Verzosa, G., Abhayaratna, W. P., Seward, J. B., Iwasaka, T., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm012 · Cited by 133
Forti, P., Maioli, F., Pisacane, N., Rietti, E., Montesi, F., & Ravaglia, G. (2007) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.01.023 · Cited by 60
Cited by
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes
Staerk, L., Sherer, J. A., Ko, D., Benjamin, E. J., & Helm, R. H. (2017) · Circulation Research · doi:10.1161/circresaha.117.309732 · Cited by 1,201
Andrade, J., Khairy, P., Dobrev, D., & Nattel, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.303211 · Cited by 1,187
Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.118 · Cited by 731
Andrade, J. G., Aguilar, M., Atzema, C., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 562
Cognitive Impairment Associated With Atrial Fibrillation: A Meta-analysis
Kalantarian, S., Stern, T. A., Mansour, M., & Ruskin, J. N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00007 · Cited by 425
A major role for cardiovascular burden in age-related cognitive decline
Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 398
Association Between Atrial Fibrillation and Dementia in the General Population
de Bruijn, R. F. A. G., Heeringa, J., Wolters, F. J., Franco, O. H., Stricker, B. H. C., Hofman, A., Koudstaal, P. J., & Ikram, M. A. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.2161 · Cited by 280
Atrial fibrillation and the risk of incident dementia: A meta-analysis
Santangeli, P., Di Biase, L., Bai, R., Mohanty, S., Pump, A., Cereceda Brantes, M., Horton, R., Burkhardt, J. D., Lakkireddy, D., Reddy, Y. M., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.07.026 · Cited by 272
The Impact of Disease Comorbidities in Alzheimer’s Disease
Santiago, J. A., & Potashkin, J. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631770 · Cited by 259
Heart disease as a risk factor for dementia
Hakim, A., Ng, & Turek (2013) · Clinical Epidemiology · doi:10.2147/clep.s30621 · Cited by 229
Atrial fibrillation and cognitive decline: A longitudinal cohort study
Thacker, E. L., McKnight, B., Psaty, B. M., Longstreth, W. T., Sitlani, C. M., Dublin, S., Arnold, A. M., Fitzpatrick, A. L., Gottesman, R. F., & Heckbert, S. R. (2013) · Neurology · doi:10.1212/wnl.0b013e31829a33d1 · Cited by 222
Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., et al. (2013) · Europace · doi:10.1093/europace/eut232 · Cited by 141
Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
Ding, M., & Qiu, C. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0159-7 · Cited by 57
Atrial fibrillation and prestroke cognitive impairment in stroke
Horstmann, S., Rizos, T., Rauch, G., Fuchs, M., Arden, C., & Veltkamp, R. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7233-3 · Cited by 20
Metadata
- Authors
- Marzona, I., O’Donnell, M., Teo, K., Gao, P., Anderson, C., Bosch, J., & Yusuf, S.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2012-02-27
- Volume
- 184
- Issue
- 6
- Pages
- E329-E336
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2102197227
- Cited by
- 238
- References
- 7
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.